Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 60-80 years old; 2.Blood PSA 4-20 ng/ml; 3.miPSMA >= 2 and PI-RADS>=4 by PSMA PET/MRI, and the time of surgery was within 3 months after the imaging examination; 4. Pre-operative imaging stage was earlier than cT3b and there was no pelvic lymph node metastasis and distant metastasis; 5. Agreed to enter this study for surgical treatment and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Presence of severe underlying diseases that cannot tolerate puncture or surgery; 2.Patients found to have local invasion or distant metastasis; 3.Presence of severe mental disorders that cannot cooperate with the treatment or study; 4.Patients with previous prostate puncture; 5.Patients with previous transurethral prostate electrocision and pelvic surgery; 6.Patients with previous or expected endocrine therapy prior to surgical treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient-based detection rate of csPCa;Lesions-based detection rate of csPCa; | — |
Secondary
| Measure | Time frame |
|---|---|
| Major tumour localisation rate;Positive surgical margins;PSA levels 6 weeks after surgery; | — |
Countries
China
Contacts
Chinese PLA General Hospital